Clinical Trial Update: VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of VNP40101M in young patients with recurrent, progressive, or refractory primary brain tumors; the study is complete.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumors
• Central Nervous System Tumors

Drugs mentioned

• VNP40101M

Snippet

Sponsor: Pediatric Brain Tumor Consortium | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED